ArticlePediatric nephrology (Berlin, Germany)2021

A global antiB cell strategy combining obinutuzumab and daratumumab in severe pediatric nephrotic syndrome.

Claire Dossier et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.